FALL FELLOWS

Preparing the FUTURE of Interventional Cardiology 

Final Program 

FALL FELLOWS 

2016 COURSES 

December 10-14, 2016 

Las Vegas, Nevada 

The Cosmopolitan of Las Vegas 

Adult Interventional 

Cardiology Course 

John M. Lasala, MD, PhD, FSCAI 

Program Chair 

Douglas E. Drachman, MD, FSCAI 

Program Co-Chair 

John C. Messenger, MD, FSCAI 


Congenital / Structural 

Heart Disease Interventional 

Cardiology Course 

Daniel S. Levi, MD, FSCAI 

Program Chair 

Damien Kenny, MD, FSCAI 


www.SCAI.org/Fellows

2016 FALL FELLOWS COURSES 

December 10-14, 2016 • Las Vegas, Nevada 

THE SMART SOLUTION 

FOR SEVERE CALCIUM 

VISIT CSI’S BOOTH TO LEARN MORE 

ABOUT ORBITAL ATHERECTOMY 

WHEN YOU SEE CALCIUM, 

THINK DIAMONDBACK. 

Visit whyorbital.com 

to find out more. 

Indication: The Diamondback 360 ® Coronary Orbital Atherectomy System (OAS) is a percutaneous orbital atherectomy system indicated to facilitate stent delivery in patients with coronary artery disease (CAD) 

who are acceptable candidates for PTCA or stenting due to de novo, severely calcified coronary artery lesions. Contraindications: The OAS is contraindicated when the ViperWire ® guide wire cannot pass across 

the coronary lesion or the target lesion is within a bypass graft or stent. The OAS is contraindicated when the patient is not an appropriate candidate for bypass surgery, angioplasty, or atherectomy therapy, or 

has angiographic evidence of thrombus, or has only one open vessel, or has angiographic evidence of significant dissection at the treatment site and for women who are pregnant or children. Warnings/Precautions: 

Performing treatment in excessively tortuous vessels or bifurcations may result in vessel damage; The OAS was only evaluated in severely calcified lesions, a temporary pacing lead may be necessary when 

treating lesions in the right coronary and circumflex arteries; On-site surgical back-up should be included as a clinical consideration; Use in patients with an ejection fraction (EF) of less than 25% has not been 

evaluated. See the instructions for use before performing Diamondback 360 coronary orbital atherectomy procedures for detailed information regarding the procedure, indications, contraindications, warnings, 

precautions, and potential adverse events. Caution: Federal law (USA) restricts this device to sale by or on the order of a physician. 

CSI and Diamondback 360 are registered trademarks of Cardiovascular Systems, Inc. ©2016 Cardiovascular Systems, Inc. EN-3444.A 0916 

877-CSI-0360 // WWW.WHYORBITAL.COM 

2 

FINAL PROGRAM


COMMERCIAL SUPPORT 

SCAI thanks the following companies 

for their generous educational grant 

support of the SCAI 2016 Fall Fellows 

Courses while taking sole responsibility 

for all content developed and 

disseminated through this event. 

Gold Supporters 

Boston Scientific 

Medtronic 

Silver Supporter 

Abbott 

Bronze Supporters 

Abiomed 

Cook Medical 

Cordis, A Cardinal Health Company 

Edwards Lifesciences 

St. Jude Medical 

Terumo Interventional Systems 

SCAI also thanks the following 

companies for support of: 

• Boston Scientific: Charging Stations 

and Registration Lanyards 

• Medtronic: SCAI 2016 Fall Fellows 

Welcome Reception 

• St. Jude Medical: Heart Dissection 

Program 

FALL FELLOWS 

2016 COURSES 

General Information ......................................... 4-7 

• Program Chairs, Faculty .................................................... 

• Course Overview, Learning Objectives ................................ 

4 

5 

• Target Audience, Attendance Certificates, Wi-Fi Password 

Content Validation Statement, Exhibit Hall Passport ............ 

• Locations & Hours: Registration Desk, 

Speaker Ready Room, Exhibit Hall, General Sessions, 

Breakout Sessions, Satellite Symposia ............................. 

Adult Course Agenda ...................................... 

Congenital / Structural Heart Disease Course 

Agenda ........................................................ 

Exhibit Hall, Exhibitor Information ................ 

Satellite Symposia Information ..................... 

6 

6-7 

8-13 

14-19 

20-21 

22-23 

SCAI 2016 FALL FELLOWS COURSES 


3



GENERAL INFORMATION 

Program Chairs 

Adult Interventional Cardiology 

Fellows Course 

Faculty 


Program Chair 

Barnes-Jewish Hospital at Washington 

University School of Medicine 

St. Louis, MO 



Massachusetts General Hospital 

Boston, MA 



University of Colorado 

Aurora, CO 

*SCAI Fellowship (FSCAI) applicant 

Congenital / Structural Heart Disease 

Interventional Cardiology Course 


Program Chair 

UCLA Medical Center 

Los Angeles, CA 



Our Lady’s Hospital for Sick Children 

Dublin, IRELAND 

J. Dawn Abbott, MD, FSCAI 

Providence, RI 

Steven R. Bailey, MD, MSCAI 

San Antonio, TX 

Darren P. Berman, MD 

Columbus, OH 

Emmanouil S. Brilakis, MD, 

PhD, FSCAI 

Dallas, TX 

Mauricio G. Cohen, MD, 

FSCAI 

Miami, FL 

David A. Cox, MD, FSCAI 

Bethlehem, PA 

V. Vivian Dimas, MD, FSCAI 

Dallas, TX 

Douglas E. Drachman, MD, 

FSCAI 

Boston, MA 

Peter L. Duffy, MD, MMM, 

FSCAI 

Pinehurst, NC 

Ted Feldman, MD, MSCAI 

Evanston, IL 

Craig E. Fleishman, MD 

Orlando, FL 

Robert Foree 

Syracuse, NY 

Matthew J. Gillespie, MD, 

FSCAI 

Philadelphia, PA 

Timothy D. Henry, MD, MSCAI 


James B. Hermiller, MD, FSCAI 

Indianapolis, IN 

Ziyad M. Hijazi, MD, MPH, 

MSCAI 

Doha, QATAR 

Eric Horlick, MD, FSCAI 

Toronto, CANADA 

Farouc A. Jaffer, MD, PhD, 

FSCAI 

Boston, MA 

Samir R. Kapadia, MD, FSCAI 

Cleveland, OH 

Navin K. Kapur, MD, FSCAI 

Boston, MA 

Saibal Kar, MD, FSCAI 



Dublin, IRELAND 

Morton J. Kern, MD, MSCAI 

Long Beach, CA 

Spencer B. King, MD 

Atlanta, GA 

John M. Lasala, MD, PhD, 

FSCAI 

St. Louis, MO 



William L. Lombardi, MD, 

FSCAI 

Seattle, WA 

Ehtisham Mahmud, MD, 

FSCAI 

San Diego, CA 

Perwaiz Meraj, MD* 

Manhasset, NY 

John C. Messenger, MD, 

FSCAI 

Aurora, CO 

Sahil A. Parikh, MD, FSCAI 

Cleveland, OH 

Sunil V. Rao, MD, FSCAI 

Durham, NC 

Kenneth Rosenfield, MD, 

MHCDS, MSCAI 

Boston, MA 

Mehdi Shishehbor, DO, MPH, 

PhD, FSCAI 

Cleveland, OH 

Adhir R. Shroff, MD, MPH, 

FSCAI 

Chicago, Il 

Molly Szerlip, MD, FSCAI 

Plano, TX 

Jonathan M. Tobis, MD, 

MSCAI 


Jennifer A. Tremmel, MD, MS, 

FSCAI 

Stanford, CA 

Zoltan G. Turi, MD, MSCAI 

New Brunswick, NJ 

George W. Vetrovec, MD, 

MSCAI 

Richmond, VA 

Evan M. Zahn, MD, FSCAI 


4 

FINAL PROGRAM


Course Overview 

The SCAI 2016 Fall Fellows Courses will provide an engaging, informal, and relaxing environment in which attendees can interact with 

internationally recognized faculty. Attendees of the course will gain an in-depth knowledge of indications, techniques, and expected 

outcomes for interventional cardiac, carotid, and endovascular procedures. The program will present a variety of practical case-based 

content as well as material of immediate value to attendees as they plan their post-fellowship practices. 

Learning Objectives 

At the conclusion of this activity participants will be able to demonstrate the ability to: 

Adult Interventional Cardiology Fellows 

Course 

Understand the fundamentals of interventional equipment 

selection; guidewires, guide catheters, stents, and balloons 

utilized in day-to-day interventional practice, utilizing case 

presentation, and didactic format. 

1. Apply recent randomized trial data related to PCI for left main 

and multivessel disease, with representative case 

presentations. 

2. Integrate appropriate use criteria with day-to-day practice, 

particularly for PCI therapy utilization. 

3. Integrate the use of various imaging modalities, including 

IVUS, OCT, and FFR. 

4. Understand the mechanics of support devices, including the 

rationale for device selection, prophylactic, and bailout 

support. 

5. Analyze case selection for surgical compared to transcatheter 

aortic valve replacement. 

6. Understand the benefits and risks of radial versus femoral 

access and assess management of complications. 

7. Apply techniques for complex coronary intervention 

including rotational atherectomy, bifurcation stenting, and 

chronic total occlusions, including case presentations. 

8. Recognize the indications for intervention in acute coronary 

syndromes. 

9. Apply appropriate utilization of adjunctive pharmacotherapy 

for coronary intervention, including anti-thrombin and 

anti-platelet strategies. 

10. Discuss ethical issues involved in selecting or turning down 

patients for complex coronary and structural heart disease 

interventions. Understand some tools that are useful in 

speaking to patient families under difficult situations. 

11. Define approaches to preventing complications, including case 

presentations highlighting methods for getting out of trouble 

when complications do occur. 

Congenital / Structural Heart Disease 

Interventional Cardiology Fellows Course 

1. Know how to stock the cardiac cath lab with appropriate 

equipment and tools so that a procedure can be performed 

effectively. 

2. Apply the proper radiation protection measures for the 

patients and operators in the cath lab, as well as know how to 

improve safety. 

3. Understand the complete hemodynamic assessment of 

congenital cardiac defects, including left to right shunt and 

right to left shunt lesions. 

4. Understand what hemodynamics are critical for Pre-Glenn and 

Pre-Fontan procedures. 

5. Recognize the various diseases that present in adults with 

congenital heart disease and their management. 

6. Recognize the various aspects of angiographic assessment of 

congenital cardiac defects and the best angiographic 

projections for each defect. 

7. Integrate new advanced imaging used during interventional 

cardiac procedures. 

8. Recognize the essential echocardiographic assessments, device 

selection, and procedural requirements and pitfalls for the 

most common congenital procedures including: 

a. ADS’s with both the Amplazter and Helex devices 

b. PDA’s with both devices and coils 

c. Transcatheter VSD closure 

d. Balloon aortic valvuloplasty 

e. Balloon pulmonary valvuloplasty 

f. Transcatheter replacement of the pulmonary valve 

g. Coil embolization of AV malformations and collaterals 

h. Interventions for aortic coarctation and 

pulmonary artery stenosis 

9. Discuss available fetal cardiac procedures. 

10. Understand the procedures that are often needed in the 

setting of HLHS. 

11. Understand the role of ECMO and other ventricular support 

devices in the cath lab. 




5




Target Audience 

This program is designed 

for fourth year 

interventional cardiology 

fellows and third and 

fourth year pediatric 

cardiology fellows interested 

in cardiac catheterization. 

Attendance 

Certificates 

Certificates of Completion / 

Attendance will be provided 

to registered attendees 

based upon completion of 

the online program 

evaluation. For questions 

regarding continuing 

medical education, please 

email cme@scai.org. 

Wi-Fi Password: 

SCAI2016 

Content Validation Statement 

The Society for Cardiovascular Angiography and 

Interventions Foundation accepts the following Content 

Validation Statements and expects all persons involved in 

its professional education activities to abide by these 

statements with regard to any recommendations for 

clinical care. 

All recommendations involving clinical medicine are 

based on evidence accepted within the profession of 

medicine as adequate justification for their indications 

and contraindications in the care of patients; and / or all 

scientific research referred to or reported in support or 

justification of a patient care recommendation conforms 

to generally accepted standards of experimental 

design, data collection and analysis. 

Win an iPad with 

Your Exhibit Hall 

Passport! 

Turn in your Exhibit Hall Passport with 25 exhibitor 

stamps to SCAI booth 220 by 2:45 PM on Tuesday for 

your chance to win an iPad. The iPad winner will be 

announced at 3:00 PM on Tuesday at SCAI booth 220. 

LOCATIONS & HOURS 

Registration Desk 

Location: Gracia Commons 

Saturday: 

Sunday: 

Monday: 

Tuesday: 

Speaker Ready Room 

Location: Brera 4 

Saturday: 

Sunday: 

Monday: 

Tuesday: 

Wednesday: 

1:00 PM – 6:00 PM 

7:00 AM – 6:00 PM 

7:00 AM – 6:00 PM 

7:00 AM – 6:00 PM 

3:00 PM – 6:00 PM 

6:30 AM – 6:00 PM 

7:00 AM – 6:00 PM 

7:00 AM – 6:00 PM 

7:00 AM – Noon 

Exhibit Hall 

Location: Gracia 1,2,5,6 

Sunday*: 9:45 AM – 6:15 PM 

Monday: 10:00 AM – 4:00 PM 

Tuesday**: 9:45 AM – 3:30 PM 

*Welcome Reception: 

Sunday, 5:15 PM – 6:15 PM 

**iPad Giveaway (Details on left): 

Tuesday, 3:00 PM 

10 YEARS. 

10,000 PATIENTS. 

1 LIFE-CHANGING 

VALVE. 

Designed Specifically 

For Pulmonary 

Valve Replacement 

The Melody valve is the longest 

studied transcatheter valve and is 

proven to delay conduit replacement: 

88.8% 

freedom from reoperation at 

7 years post-implant * 

Melody 

Transcatheter Pulmonary 

Valve Therapy 

* 

US IDE Study 

6 

Melody-TPV.com 

The Melody TPV System first received CE mark in September 2006. 

Medtronic, Medtronic logo and Further, Together are trademarks of Medtronic. 

All other brands are trademarks of a Medtronic company. 

FINAL PROGRAM 

UC201703124 EN 12/2016 ©2016 Medtronic. All rights reserved.


General Sessions 

Adult Interventional Cardiology Fellows Course 

Location: Gracia 4,8 

Sunday – Wednesday (View session times on pages 8-13) 

Jeopardy Game & Reception: Monday, 5:30 PM – 6:30 PM 

Breakout Sessions 

Sunday 

1:30 PM – 2:30 PM 

Monday 

1:30 PM – 2:30 PM 

Tuesday 

1:30 PM – 2:30 PM 

Satellite Symposia 

Exhibit Hall Tour 


Round Table Case Review 

Location: Castellana 1-2 

Career Advice Panel 

Location: Brera 2-3 

Symposia Open to All Attendees 


Saturday – Tuesday (View symposia times on pages 22-23) 

Congenital / Structural Heart Disease Interventional 

Cardiology Fellows Course 

Location: Gracia 3 

Sunday – Wednesday (View session times on pages 14-19) 

Group A Group B Group C 













Lunch Symposia for Congenital Program Only 

Locations: Brera 5-6 (Sunday); Brera 2-3 (Tuesday) 

Sunday & Tuesday (View symposia times on pages 22-23) 

LOCATIONS & HOURS 

Melody Transcatheter Pulmonary Valve 

Ensemble II Transcatheter Valve Delivery System 

Important Labeling Information for United States 

Indications: The Melody TPV is indicated for use as an adjunct to surgery in the management 

of pediatric and adult patients with the following clinical conditions: 

· Existence of a full (circumferential) RVOT conduit that was equal to or greater than 16 mm in diameter 

when originally implanted AND 

· Dysfunctional RVOT conduits with a clinical indication for intervention, AND 

- regurgitation: ≥ moderate regurgitation, AND/OR 

- stenosis: mean RVOT gradient ≥ 35 mm Hg 

Contraindications: None known. 

Warnings/Precautions/Side Effects: 

· DO NOT implant in the aortic or mitral position. Preclinical bench testing of the Melody valve suggests 

that valve function and durability will be extremely limited when used in these locations. 

· DO NOT use if patient’s anatomy precludes introduction of the valve, if the venous anatomy cannot 

accommodate a 22 Fr size introducer, or if there is significant obstruction of the central veins. 

· DO NOT use if there are clinical or biological signs of infection including active endocarditis. Standard 

medical and surgical care should be strongly considered in these circumstances. 

· Assessment of the coronary artery anatomy for the risk of coronary artery compression should be 

performed in all patients prior to deployment of the TPV. 

· To minimize the risk of conduit rupture, do not use a balloon with a diameter greater than 110% of 

the nominal diameter (original implant size) of the conduit for pre-dilation of the intended site of 

deployment, or for deployment of the TPV. 

· The potential for stent fracture should be considered in all patients who undergo TPV placement. 

Radiographic assessment of the stent with chest radiography or fluoroscopy should be included in the 

routine postoperative evaluation of patients who receive a TPV. 

· If a stent fracture is detected, continued monitoring of the stent should be performed in conjunction 

with clinically appropriate hemodynamic assessment. In patients with stent fracture and significant 

associated RVOT obstruction or regurgitation, reintervention should be considered in accordance 

with usual clinical practice. 

Potential procedural complications that may result from implantation of the Melody device include 

the following: rupture of the RVOT conduit, compression of a coronary artery, perforation of a major 

blood vessel, embolization or migration of the device, perforation of a heart chamber, arrhythmias, 

allergic reaction to contrast media, cerebrovascular events (TIA, CVA), infection/sepsis, fever, 

hematoma, radiation-induced erythema, blistering, or peeling of skin, pain, swelling, or bruising at the 

catheterization site. 

Potential device-related adverse events that may occur following device implantation include the 

following: stent fracture, *stent fracture resulting in recurrent obstruction, endocarditis, embolization 

or migration of the device, valvular dysfunction (stenosis or regurgitation), paravalvular leak, valvular 

thrombosis, pulmonary thromboembolism, hemolysis. 

* The term “stent fracture” refers to the fracturing of the Melody TPV. However, in subjects with multiple 

stents in the RVOT it is difficult to definitively attribute stent fractures to the Melody frame versus 

another stent. 

For additional information, please refer to the Instructions For Use provided with the product. 


CAUTION: Federal law (USA) restricts this device to sale by or on the order of a physician. 

Important Labeling Information for 

Geographies Outside of the United States 

Indications: The Melody Transcatheter Pulmonary Valve is indicated for use in patients with the 

following clinical conditions: 

· Patients with regurgitant prosthetic Right Ventricular Outflow Tract (RVOT) conduits with a clinical 

indication for invasive or surgical intervention, OR 

· Patients with stenotic prosthetic RVOT conduits where the risk of worsening regurgitation is a relative 

contraindication to balloon dilation or stenting. 

· Existence of a full (circumferential) RVOT conduit that was equal to or greater than 16 mm in diameter 

when originally implanted. 

The intended lifetime for the Melody device is 2 years. 

Contraindications: 

· Venous anatomy unable to accommodate a 22 Fr size introducer sheath; implantation in left heart. 

· Unfavorable right ventricular outflow tract for good stent anchorage. 

· Severe right ventricular outflow obstruction, which cannot be dilated by balloon. 

· Obstruction of the central veins. 

· Clinical or biological signs of infection. 

· Active endocarditis. 

· Known allergy to aspirin or heparin. 

· Pregnancy. 

Potential Complications/Adverse Events: Potential procedural complications that may result from 

implantation of the Melody device include the following: rupture of the RVOT conduit, compression 

of a coronary artery, perforation of a major blood vessel, embolization or migration of the device, 

perforation of a heart chamber, arrhythmias, allergic reaction to contrast media, cerebrovascular 

events (TIA, CVA), infection/sepsis, fever, hematoma, radiation-induced erythema, pain at the 


Potential device-related adverse events that may occur following device implantation include the 

following: stent fracture resulting in recurrent obstruction, endocarditis, embolization or migration 

of the device, valvular dysfunction (stenosis or regurgitation), paravalvular leak, valvular thrombosis, 

pulmonary thromboembolism, hemolysis. 

For additional information, please refer to the Instructions For Use provided with the product. 

The Melody Transcatheter Pulmonary Valve and Ensemble II Transcatheter Delivery System has 

received CE Mark approval and is available for distribution in Europe. 


7



ADULT COURSE AGENDA 

Saturday, December 10, 2016 

Satellite Half-Day Event 

3:00 PM – 8:00 PM | Castellana 1-2 

Sunday, December 11, 2016 

Satellite Breakfast Event 

6:30 AM – 8:00 AM | Castellana 1-2 

Course Introduction 

8:15 AM – 8:20 AM | Gracia 4,8 

Speaker: John M. Lasala, MD, PhD, FSCAI 

Fundamentals for PCI 

8:20 AM - 10:00 AM | Gracia 4,8 

Moderators: Douglas E. Drachman, MD, FSCAI; John M. Lasala, MD, PhD, FSCAI 

8:20 AM 

8:50 AM 

Keynote Speaker: History of Interventional Cardiology 

Balloons and Stents 

Spencer B. King, MD 


9:10 AM 

9:22 AM 

9:34 AM 

9:46 AM 

Tips and Tricks of Guidewires and Guide Catheters 

Case Presentation: Tortuous Anatomy, Proximal Calcification 

Fellows Case Presentation by Todd James, MD 

Questions and Answers 

Emmanouil S. Brilakis, MD, PhD, FSCAI 

Steven R. Bailey, MD, MSCAI 

Douglas E. Drachman, MD, FSCAI (Mentor) 

Open Discussion with Faculty 

Break / Visit Exhibits 

10:00 AM – 10:45 AM | Gracia 1,2,5,6 

Access 

10:45 AM - Noon | Gracia 4,8 

Moderators: Morton J. Kern, MD, MSCAI; Sunil V. Rao, MD, FSCAI 

10:45 AM 

10:56 AM 

11:07 AM 

11:18 AM 

11:29 AM 

11:40 AM 

11:52 AM 

Radial Basics 

Femoral Basics 

Tips and Tricks for Radials 

Case Presentation: Radial and Femoral Access Complications 

Large Sheath Access and Closure 

Fellows Case Presentation by Sushant Khair, MD 


Jennifer A. Tremmel, MD, MS, FSCAI 

Ehtisham Mahmud, MD, FSCAI 

Sunil V. Rao, MD, FSCAI 


Mauricio G. Cohen, MD, FSCAI 

Steven R. Bailey, MD, MSCAI (Mentor) 


Satellite Lunch Event 


8 

FINAL PROGRAM


Sunday, December 11, 2016 (Continued) 

Concurrent Breakout Sessions 

1:30 PM – 2:30 PM | Gracia 1,2,5,6 (Group A); Castellana 1-2 (Group B); Brera 5-6 (Group C) 

Group A: Exhibit Hall Tour 

• Steven R. Bailey, MD, MSCAI; Ted Feldman, MD, MSCAI; Morton J. Kern, MD, MSCAI; John M. Lasala, MD, PhD, FSCAI; 

George W. Vetrovec, MD, MSCAI 

Group B: Round Table Case Review 

• Emmanouil S. Brilakis, MD, PhD, FSCAI; Mauricio G. Cohen, MD, FSCAI; Peter L. Duffy, MD, MMM, FSCAI; 

James B. Hermiller, MD, FSCAI; John C. Messenger, MD, FSCAI; Sahil A. Parikh, MD, FSCAI; Jonathan M. Tobis, MD, MSCAI 

Group C: Career Advice Panel 

• Douglas E. Drachman, MD, FSCAI; Ehtisham Mahmud, MD, FSCAI; Jennifer A. Tremmel, MD, MS, FSCAI 

Imaging and Diagnostic Techniques 

2:30 PM – 3:30 PM | Gracia 4,8 

Moderators: Ehtisham Mahmud, MD, FSCAI; Jonathan M. Tobis, MD, MSCAI 

2:30 PM 

2:45 PM 

3:05 PM 

FFR / iFR 

IVUS and OCT 

Reducing Occupational Hazards in the Cath Lab 

Morton J. Kern, MD, MSCAI 


Ehtisham Mahmud, MD, FSCAI 


3:20 PM 




3:30 PM – 4:00 PM | Gracia 1,2,5,6 

Getting In and Out of Trouble 

4:00 PM – 5:15 PM | Gracia 4,8 

Moderators: Douglas E. Drachman, MD, FSCAI; John C. Messenger, MD, FSCAI 

4:00 PM 

4:13 PM 

4:26 PM 

4:39 PM 

4:52 PM 

5:05 PM 

Preventing Complications in the First Place 

Handling the Four Basic Cath Lab Catastrophes 

Pericardiocentesis 

Coiling and Plugging Your Way Out of Trouble 

Case Presentation: Getting Out of Trouble 





Matthew J. Gillespie, MD, FSCAI 

Emmanouil S. Brilakis, MD, PhD, FSCAI 


Welcome Reception in Exhibit Hall 

5:15 PM – 6:15 PM | Gracia 1,2,5,6 

Satellite Dinner Event 

6:30 PM - 8:30 PM | Castellana 1-2 

Monday, December 12, 2016 





9




Monday, December 12, 2016 (Continued) 

The MACRA Primer: Getting Paid for What You Do 

8:15 AM – 8:30 AM | Gracia 4,8 

Speaker: Peter L. Duffy, MD, MMM, FSCAI 

PCI: Left Main and Multivessel 

8:30 AM – 10:00 AM | Gracia 4,8 

Moderators: Steven R. Bailey, MD, MSCAI; Adhir R. Shroff, MD, MPH, FSCAI 

8:30 AM 

9:00 AM 

9:12 AM 

9:24 AM 

9:36 AM 

9:48 AM 

Keynote Speaker: Top Ten Trials of the Year 

Left Main Intervention / Multivessel Intervention 

Assessing Myocardium at Risk: Applying SYNTAX 

Case Presentation: Multivessel Non-Left Main 

Fellows Case Presentation by Raveen Kandan, MD 



10:00 AM – 10:45 AM | Gracia 1,2,5,6 



Farouc A. Jaffer, MD, PhD, FSCAI 


Adhir R. Shroff, MD, MPH, FSCAI (Mentor) 


High-Risk Interventions and Support Technology 

10:45 AM – Noon | Gracia 4,8 

Moderators: Ted Feldman, MD, MSCAI; Navin K. Kapur, MD, FSCAI 

10:45 AM 

10:57 AM 

11:09 AM 

11:21 AM 

11:34 AM 

11:46 AM 

Treatment of Saphenous Vein Grafts (SVG) 

Rationale for LV Support during PCI and When to Use Them 

Case Presentation: Prophylactic Support 

Case Presentation: Bailout Support 

Fellows Case Presentation by Samar Sheth, MD 





Jonathan M. Tobis, MD, MSCAI 

Navin K. Kapur, MD, FSCAI (Mentor) 


Concurrent Satellite Lunch Events 

12:15 PM – 1:15 PM | Castellana 1-2 (Concurrent Lunch Event 1); Brera 5-6 (Concurrent Lunch Event 2) 


1:30 PM – 2:30 PM | Castellana 1-2 (Group A); Brera 5-6 (Group B); Gracia 1,2,5,6 (Group C) 

Group A: Round Table Case Review 

• Steven R. Bailey, MD, MSCAI; David A. Cox, MD, FSCAI; Farouc A. Jaffer, MD, PhD, FSCAI; Morton J. Kern, MD, MSCAI; 

John M. Lasala, MD, PhD, FSCAI; William L. Lombardi, MD, FSCAI; George W. Vetrovec, MD, MSCAI 

Group B: Career Advice Panel 

• John C. Messenger, MD, FSCAI; Kenneth Rosenfield, MD, MHCDS, MSCAI; Molly Szerlip, MD, FSCAI 

Group C: Exhibit Hall Tour 

• Mauricio G. Cohen, MD, FSCAI; Douglas E. Drachman, MD, FSCAI; Timothy D. Henry, MD, MSCAI; Sahil A. Parikh, MD, FSCAI; 


10 

FINAL PROGRAM



Complex PCI 

2:30 PM – 3:30 PM | Gracia 4,8 

Moderators: Ted Feldman, MD, MSCAI; John M. Lasala, MD, PhD, FSCAI 

2:30 PM 

2:45 PM 

3:00 PM 

3:15 PM 


3:30 PM – 4:00 PM | Gracia 1,2,5,6 

STEMI, ACS and Shock 

4:00 PM – 5:30 PM | Gracia 4,8 

Moderators: David A. Cox, MD, FSCAI; Timothy D. Henry, MD, MSCAI 

4:00 PM 

4:13 PM 

Rotational / Orbital Atherectomy Case Examples 

Bifurcations 

CTO’s: Do’s and Don’ts 

Case Presentation: Complex Bifurcation Lesion with Questions and 

Answers 

STEMI 

ACS / NSTEMI: When to Intervene and When Not? 



William L. Lombardi, MD, FSCAI 

Perwaiz Meraj, MD 




4:26 PM 

4:39 PM 

4:51 PM 

5:03 AM 

5:15 PM 

Debate: Radial vs. Femoral 

Treatment Algorithm for Cardiogenic Shock 

Case Presentation: NSTEMI No Reflow 

Case Presentation: STEMI 

Presidential Address 

David A. Cox, MD, FSCAI; 



Farouc A. Jaffer, MD, PhD, FSCAI 


Kenneth Rosenfield, MD, MHCDS, MSCAI 

Jeopardy 

5:30 PM – 6:30 PM | Gracia 4,8 

Moderators: Morton J. Kern, MD, MSCAI; George W. Vetrovec, MD, MSCAI 

Faculty Contestants: Douglas E. Drachman, MD, FSCAI; John C. Messenger, MD, FSCAI; Jonathan M. Tobis, MD, MSCAI 



Tuesday, December 13, 2016 



St. Jude Heart Dissection 

8:30 AM – 10:00 AM | Brera 5-6 

Presenter: Robert Foree, Senior Manager, Structural Heart Global Education, St. Jude Medical 


10:00 AM – 10:45 AM | Gracia 1,2,5,6 



11




Tuesday, December 13, 2016 (Continued) 

Valve and Structural Therapy - Part 1: LAA, ASD, and PFO 

10:45 AM – Noon | Gracia 4,8 

Moderators: Samir R. Kapadia, MD, FSCAI; Saibal Kar, MD, FSCAI 

10:45 AM 

10:56 AM 

11:07 AM 

11:18 AM 

11:29 AM 

11:40 AM 

11:52 AM 

ASD: Indications and Approaches 

Paravalvular Leaks 

PFO Closure for Stroke, Migraines and Hypoxemia 

Left Atrial Appendage Closure 

Case Presentation: Left Atrial Appendage Closure 

Fellows Case Presentation by Amy Gin, MD 





1:30 PM – 2:30 PM | Brera 2-3 (Group A); Gracia 1,2,5,6 (Group B); Castellana 1-2 (Group C) 






John M. Lasala, MD, PhD, FSCAI (Mentor) 


Group A: Career Advice Panel 

• J. Dawn Abbott, MD, FSCAI; John M. Lasala, MD, PhD, FSCAI; Mauricio G. Cohen, MD, FSCAI 

Group B: Exhibit Hall Tour 

• James B. Hermiller, MD, FSCAI; John C. Messenger, MD, FSCAI; Sahil A. Parikh, MD, FSCAI; Zoltan G. Turi, MD, MSCAI; 


Group C: Round Table Case Review 

• Douglas E. Drachman, MD, FSCAI; Timothy D. Henry, MD, MSCAI; Samir R. Kapadia, MD, FSCAI; Saibal Kar, MD, FSCAI; 

Perwaiz Meraj, MD; Molly Szerlip, MD, FSCAI; Jonathan M. Tobis, MD, MSCAI 


2:30 PM – 3:00 PM | Gracia 1,2,5,6 

Valve and Structural Therapy - Part 2: Transseptal, Mitral, and Aortic 

3:00 PM – 4:30 PM | Gracia 4,8 

Moderators: Jonathan M. Tobis, MD, MSCAI; Zoltan G. Turi, MD, MSCAI 

3:00 PM 

3:12 PM 

3:24 PM 

3:36 PM 

3:48 PM 

4:00 PM 

4:12 PM 

4:24 PM 

Transseptal Basics 

Mitral Valvuloplasty 

TAVR: Matching Devices to Patients 

Case Presentation: TAVR Complication 

MitraClip Therapy and Beyond 

Case Presentation: MitralClip Complication 

Fellows Case Presentation by Brett Bennett, MD 



Zoltan G. Turi, MD, MSCAI 





Molly Szerlip, MD, FSCAI (Mentor) 


Coronary Topics 

4:30 PM – 6:15 PM | Gracia 4,8 

Moderators: Perwaiz Meraj, MD; Molly Szerlip, MD, FSCAI 

4:30 PM How to Treat Complex Stenosis 

Roxana Mehran, MD, FSCAI 

12 

FINAL PROGRAM



Coronary Topics (Continued) 

4:30 PM – 6:15 PM | Gracia 4,8 

Moderators: Perwaiz Meraj, MD; Molly Szerlip, MD, FSCAI 

4:44 PM 

4:58 PM 

5:11 PM 

5:25 PM 

5:38 PM 

5:52 PM 

6:04 PM 

High-Risk PCI 

Case Presentation: Complex PCI Success Story 

PCI in the Last Remaining Vessel 

Case Presentation: Complex PCI Not so Successful Story 

Procedural Strategies: When to Do Ad Hoc PCI and When to Stage 

Multivessel PCI 

Fellows Case Presentation by Sunay Shah, MD 




Wednesday, December 14, 2016 

Breakfast 

7:30 AM – 8:30 AM | Gracia Foyer 






James B. Hermiller, MD, FSCAI (Mentor) 



Peripherals 

8:30 AM – 10:00 AM | Gracia 4,8 

Moderators: J. Dawn Abbott, MD, FSCAI; Mehdi Shishehbor, DO, MPH, PhD, FSCAI 

8:30 AM 

8:41 AM 

9:03 AM 

9:14 AM 

9:25 AM 

9:36 AM 

9:47 AM 

Carotid Intervention 

Renal Intervention 

Lower Extremity Revascularization 

Case Presentation: Fixing Your Iatrogenic Complications 

Alternate Peripheral Access 

Fellows Case Presentation by Mike Young, MD 


Mehdi Shishehbor, DO, MPH, PhD, FSCAI 




Mehdi Shishehbor, DO, MPH, PhD, FSCAI 

J. Dawn Abbott, MD, FSCAI (Mentor) 


Break 


My Most Instructive Case of the Year 

10:30 AM – 11:45 AM | Gracia 4,8 

Moderator: John M. Lasala, MD, PhD, FSCAI 

10:30 AM 

10:50 AM 

11:10 AM 

11:30 AM 

Case Presentation: The Most Instructive Coronary Case of the Year 

Case Presentation: The Most Instructive Structural Case of the Year 

Case Presentation: The Most Instructive Peripheral Case of the Year 

Closing Remarks 







13



CONGENITAL / STRUCTURAL HEART DISEASE COURSE AGENDA 

Saturday, December 10, 2016 

Satellite Half-Day Event 


Sunday, December 11, 2016 



Session 1: Introduction to a Career in Congenital Interventions - Cath Lab, Equipment, Access and Career Advice 

8:00 AM – 9:35 AM | Gracia 3 

Moderators: Damien Kenny, MD, FSCAI; Daniel S. Levi, MD, FSCAI 

8:00 AM 

8:05 AM 

8:20 AM 

8:35 AM 

8:50 AM 

9:05 AM 

9:20 AM 

Welcome: Course Overview and Introductions 

Building a Career in Congenital Catheterization: Career Advice in the First 

Year After Fellowship 

Ten Tips for Building a Successful Career in Congenital Catheterization 

The Working Pediatric Catheterization Lab 

Things We Use in the Cath Lab: Catheters, Wires, Balloons, Stents, Devices, Etc. 

Vascular Access and Vascular Closure Devices 

Discussion 


9:45 AM – 10:30 AM | Gracia 1,2,5,6 

Session 2: Diagnostic Catheterization in Congenital Heart Disease 

10:45 AM – Noon | Gracia 3 

Moderators: V. Vivian Dimas, MD, FSCAI; Daniel S. Levi, MD, FSCAI 

10:45 AM 

11:00 AM 

11:15 AM 

11:30 AM 

11:45 AM 

Basic Hemodynamic Assessment: Waveforms, Shunt Calculations and 

Cardiac Output Assessment 

Advanced Hemodynamic Assesment: Case-Based Examples of Tamponade, 

Valve Area, Shunt and P-Htn Decision Making 

The Art of Angiography: Diagnostic Needs - Interventional Projections, 

Locations, Etc. 

Diagnostic Cardiac Caths: Pre-Glenn and Pre-Fontan... What are We Looking For? 

Diagnostic / Angiographic Interactive Case Presentation 


12:15 PM – 1:15 PM | Brera 5-6 

Session 3: ASD and PFO Closure in Children 

1:30 PM – 3:05 PM | Gracia 3 

Moderators: Matthew J. Gillespie, MD, FSCAI; Ziyad M. Hijazi, MD, MPH, MSCAI 






Ziyad M. Hijazi, MD, MPH, MSCAI 

Session Faculty 






1:30 PM Imaging Assessment of the Atrial Septum 


14 

FINAL PROGRAM


Sunday, December 11, 2016 (Continued) 

Session 3: ASD and PFO Closure in Children (Continued) 

1:30 PM – 3:05 PM | Gracia 3 

Moderators: Matthew J. Gillespie, MD, FSCAI; Ziyad M. Hijazi, MD, MPH, MSCAI 

1:45 PM 

2:00 PM 

2:15 PM 

2:30 PM 

2:50 PM 


3:05 PM – 3:45 PM | Gracia 1,2,5,6 

Session 4: VSD’s - Imaging and Device Closure 

3:45 PM – 5:00 PM | Gracia 3 

Moderators: Darren P. Berman, MD; Damien Kenny, MD, FSCAI 

3:45 PM 

4:00 PM 

4:15 PM 

4:30 PM 

4:45 PM 

ASD Closure Debate: Why Using the Amplatzer Device Is Superior to Using 

the Gore Device 

ASD Closure Debate: Why Using the Gore Device Is Superior to Using the 

Amplatzer Device Closure 

Closure of PFO’s and ASD’s: Using OUS Devices 

ASD: Interactive Case Presentation 

Discussion 

Imaging Evaluation of the Ventricular Septum 

Transcatheter Closure of Muscular and PmVSD 

Perventricular Closure of Muscular VSD 

Interactive Case Presentation: Decision Making in VSD Closure 

Discussion 

Welcome Reception in Exhibit Hall 

5:15 PM – 6:15 PM | Gracia 1,2,5,6 



Monday, December 12, 2016 



Session 5: Embolization Therapy - APC, Coronary Fistulas, AVMs and PDAs 

8:00 AM – 9:30 AM | Gracia 3 

Moderators: Matthew J. Gillespie, MD, FSCAI; Daniel S. Levi, MD, FSCAI 

8:00 AM 

8:15 AM 

8:30 AM 

8:45 AM 

APC’s and Coronary Artery Fistulas 

PAVMS’s and Venovenous Collaterals 

PDA Closure 

PDA Stenting 




Ziyad M. Hijazi, MD, MPH, MSCAI; 















15





Session 5: Embolization Therapy - APC, Coronary Fistulas, AVMs and PDAs (Continued) 

8:00 AM – 9:30 AM | Gracia 3 

Moderators: Matthew J. Gillespie, MD, FSCAI; Daniel S. Levi, MD, FSCAI 

9:00 AM 

9:15 AM 

Session 6: Complications, Retrievals, and Safety - QI 

9:30 AM – 11:15 AM | Gracia 3 

Moderators: Darren P. Berman, MD; V. Vivian Dimas, MD, FSCAI 

9:30 AM 

9:45 AM 

10:00 AM 

10:15 AM 

10:30 AM 

10:45 AM 

11:00 AM 

Radiation Safety in the Cath Lab 

Retrieval Techniques: Snares, Baskets, Bioptomes 

Utilizing SCAI QI Resources 

Vascular Complications and Management 

Pericardiocentesis: Indications and Techniques in Pediatric and Adult Patients 

Interactive Case Presentation of Retrieval Technique 

Discussion 

Break & Exhibit Hall Tour 

11:15 AM – 12:45 PM | Gracia 1,2,5,6 

Lunch / Visit Exhibits 

12:45 PM – 1:30 PM | Gracia 1,2,5,6 

Session 7: Branch Pulmonary Arteries Stenosis - Angioplasty-Cutting Balloons and Stents 

1:30 PM – 3:00 PM | Gracia 3 

Moderators: Damien Kenny, MD, FSCAI; Evan M. Zahn, MD, FSCAI 

1:30 PM 

1:45 PM 

2:00 PM 

2:15 PM 

2:30 PM 

2:45 PM 

PDA Closure in the Very Small Infant: Interactive Case Presentation 

Discussion 

Angiography of the Branch Pulmonary Arterial Tree 

Angioplasty - Conventional and Cutting Balloons: Indications, Preparations, 

Techniques, and Outcomes 

Stent Implantation for PPS: Indications, Types of Stents, Techniques of 

Deployment, Complications, and Outcomes 

Pulmonary Artery Intervention: Interactive Case Presentation 

Discussion 

Presidential Address 


3:00 PM – 4:00 PM | Gracia 1,2,5,6 

Session 8: Pulmonary Valve Interventions 

4:15 PM – 6:00 PM | Gracia 3 

Moderators: Ziyad M. Hijazi, MD, MPH, MSCAI; Eric Horlick, MD, FSCAI 















Kenneth Rosenfield, MD, MHCDS, MSCAI 

4:15 PM Imaging Assessment of the Pulmonary Valve in Stenosis / Atresia and Craig E. Fleishman, MD 

Regurgitation 

16 

FINAL PROGRAM



Session 8: Pulmonary Valve Interventions (Continued) 

4:15 PM – 6:00 PM | Gracia 3 

Moderators: Ziyad M. Hijazi, MD, MPH, MSCAI; Eric Horlick, MD, FSCAI 

4:30 PM 

4:45 PM 

5:00 PM 

5:15 PM 

5:30 PM 

5:45 PM 



Tuesday, December 13, 2016 



Session 9: Imaging - Cross Sectional, TEE, and ICE in the Congenital Cath Lab 

8:00 AM – 9:30 AM | Gracia 3 

Moderators: Craig E. Fleishman, MD; Evan M. Zahn, MD, FSCAI 

8:00 AM 

8:15 AM 

8:30 AM 

8:45 AM 

9:00 AM 

9:15 AM 

Balloon Valvuloplasty / RF Perforation for Patients with Critical PS and/or PA / IVS 

Pulmonary Valve Implantation with the Edwards Sapien Valve: My Approach 

Pulmonary Valve Implantation Medtronic Melody Valve: My Approach 

Native Outflow Tract Transcatheter Pulmonary Valve Replacement 

Transcatheter Pulmonary Valve Implantation: Interactive Case Presentation 

Discussion 

Debate: TEE Imaging and Why It Is Better than ICE in the Congenital Cath Lab 

Debate: ICE for Imaging and Why It Is Preferred for Congenital Interventions 

Rotational Angiography and Utilizing CT / MRI with Fluoroscopy 

How to Image the Coronaries in CHD Patients 

Interactive Case Presentation: Ultrasound Guidance for Congenital Intervention 

Discussion 


9:45 AM – 10:15 AM | Gracia 1,2,5,6 

Session 10: Aortic Valve Interventions and Interventions for Aortic Coarctation 


Moderators: Craig E. Fleishman, MD; Daniel S. Levi, MD, FSCAI 

10:15 AM 

10:30 AM 

10:45 AM 

11:00 AM 

11:15 AM 

Imaging Assessment of AS / AR 

Balloon Aortic Valvuloplasty in Infants and Children: Indications, Techniques 

and Outcomes 

Balloon Aortic Valvuloplasty in the Fetus 

Coarctation Stenting in Adults 

Coarctation Stenting and Angioplasty in Infants and Children: Indications, 

Guidelines, Techniques, and Outcomes 





















17





Session 10: Aortic Valve Interventions and Interventions for Aortic Coarctation (Continued) 


Moderators: Craig E. Fleishman, MD; Daniel S. Levi, MD, FSCAI 

11:30 AM 

11:45 AM 


12:15 PM – 1:15 PM | Brera 2-3 

Session 11: MISC - HLHS, Atrial Septostomy and Other Hybrid Interventions 

1:30 PM – 2:45 PM | Gracia 3 

Moderators: Darren P. Berman, MD; Craig E. Fleishman, MD 

1:30 PM 

1:45 PM 

2:00 PM 

2:15 PM 

2:30 PM 


2:45 PM – 3:30 PM | Gracia 1,2,5,6 

Session 12: The Adult with Congenital Heart Disease 

3:45 PM – 5:00 PM | Gracia 3 

Moderators: V. Vivian Dimas, MD, FSCAI; Eric Horlick, MD, FSCAI 

3:45 PM 

4:00 PM 

4:15 PM 

4:30 PM 

4:45 PM 

Evaluation and Management of Adults with CHD 

Catheterization of Adults with Single Ventricles 

Fontan Interventions 

Catheterization of Adults after TGA Repair 

Discussion 

Session 13: Fellows Case Presentations 

5:00 PM – 6:15 PM | Gracia 3 

Moderator: Matthew J. Gillespie, MD, FSCAI; Evan M. Zahn, MD, FSCAI 

5:00 PM 

5:15 PM 

5:30 PM 

5:45 PM 

6:00 PM 

Aortic Intervention: Interactive Case Presentation 

Discussion 

Echo Assessment of HLHS 

Hybrid Management of HLHS: Indications, Techniques, and Outcomes 

Opening the Atrial Septum: Transseptal Access, Balloon Septostomy, and 

Stenting 

Hybrid Procedures: Alternate Approaches to Stenting and Transcatheter 

Valve Placement 

Discussion 

Cardiac Perforation During Pericardiocentesis, How I Escaped! 

Mitral Valve-in-Valve Case 

Common Methods in Uncommon Patients 

Atrial Septal Defect Closure Utilizing a Fenestrated Device 

Difficult Edwards Sapien XT Valve 



Eric Horlick, M.D., FSCAI 












Amitoz Singh Baidwan, MD 

Alaeldin Eltom, MD 

Andrew Ho, MD 

Kaitlin L’Italien, MD 

Ugonna Nwankwo, MD 

18 

FINAL PROGRAM


Wednesday, December 14, 2016 

Breakfast 


St. Jude Heart Dissection 

8:00 AM – 10:00 AM | Brera 5-6 

Presenter: Robert Foree, Senior Manager, Structural Heart Global Education, St. Jude Medical 

Break 


Session 13: Fellows Case Presentations 

10:15 AM – 11:45 AM | Gracia 3 

Moderator: Damien Kenny, MD, FSCAI; Daniel S. Levi, MD, FSCAI 

10:15 AM 

10:30 AM 

10:45 AM 

11:00 AM 

11:15 AM 

11:30 AM 

Management of Baffle Leak and Stenosis in a Mustard Patient 

Complex Single Ventricle with Pulmonary AVMs 

The Domino Effect: A Case of Iatrogenic Autotransfusion 

Curb Your Enthusiasm 

Percutaneous Posttraumatic VSD Closure 

Summary, Discussion and Closing Remarks 

Let SCAI Help You Launch Your Career! 

Launch your career with the only global organization solely dedicated to advancing interventional and invasive cardiology 

– The Society for Cardiovascular Angiography and Interventions Foundation (SCAI). The following are just some of the free 

resources SCAI offers interventional / invasive Fellows-in-Training. Visit SCAI booth 220 to learn about these benefits. 

SCAI C3 Summit for 

Graduating FIT’s 

www.SCAI.org/C3 

SCAI’s Complex Coronary Complications 

(C3) Summit is an outstanding opportunity 

to enhance your professional skills and 

broaden your training as you complete 

your interventional fellowship. 

Held in conjunction with SCAI 2017 

Scientific Sessions in New Orleans from 

May 10-13, 2017, grant recipients receive 

a complimentary registration for SCAI 

2017 (including the C3 Summit), hotel 

accommodations and up to $500 in airfare 

(restrictions apply). 

Interventional Job Bank 

www.SCAI.org/JobBank 

Search the SCAI Job Bank for 

interventional and invasive cardiology jobs 

across the United States. Register for SCAI 

Job Bank job alerts for positions that match 

your qualifications and post your resumé 

to have employers come to you! 

eLearning Library 

www.SCAI.org/eLearning 

Experience the advantages of SCAI 

eLearning! SCAI is proud to offer a 

growing collection of online, easy-toaccess, 

cost-effective, high-quality, CME 

educational programs as a complement to 

our live meetings and courses for 

interventional cardiologists, Fellows-in- 

Training, and other physicians and 

professionals with an interest in invasive 

and interventional cardiology. 

SCAI Fellows-in- 

Training (FIT) Portal 

www.SCAI.org/FIT 

Visit the SCAI Fellows-in-Training (FIT) 

Portal, featuring a FIT Core Curriculum, 

career development resources, the latest 

on live meetings, and an online, mobilefriendly 

Procedure Log. Through exceptional 

education and the most current 

resources, the SCAI FIT Portal prepares 

today’s Fellows to be tomorrow’s premier 

Interventional Cardiologists. 


Biagio Castaldi, MD 

Neil Patel, MD 

Michele Pighi, MD 

Sanjay Sinha, MD 

Nataliia Yashchuk, MD 

Moderators 

Free Fellows-in-Training Membership 

www.SCAI.org/Join 

Fellows-in-Training (FIT) in interventional / invasive cardiology 

who join SCAI receive a number of FIT membership benefits 

including a free online subscription to Catheterization & 

Cardiovascular Interventions (CCI), full access to members-only 

resources on www.SCAI.org, members-only emails, and are 

eligible to join SCAI committees early in their career. 

Free First Year of Membership 

Post-Training 

www.SCAI.org/FirstYearDiscount 



NEW! 

FREE 1 st Year 

Membership 

Post-Training 

(Details below) 

Once you complete your fellowship, submit your SCAI 

membership application and the first year’s dues as a SCAI 

member are on us! Benefits for members post-training not only 

include discounted registration for SCAI meetings and webinars, 

access to educational members-only website pages, CCI online, 

and the SCAI Job Bank, but news you’ll need in your practice, a 

voice advocating for you on Capitol Hill, and the opportunity to 

apply for the SCAI Fellow (FSCAI) designation. 

19

ROUND 

SCAI 2016 

DECEMBER 11-13, 2016 


GRACIA BALLROOM 1,2,5 & 6 - COSMOPOLITAN - LAS VEGAS, NV 


By: BRIANNE MCDEDE 

BOOTH COUNT 

Inventory as of 09/26/2016 

Dimension 

10'x10' 

10'x20' 

Size 

100 

200 

Qty 

22 

7 

SqFt 

2,200 

1,400 

Totals: 

29 

3,600 

EXHIBITOR INFORMATION 

Main 

Entrance 

Exhibit Hall 


Cardiovascular 

Systems Inc. 

121 

B. Braun 

Interventional 

Systems 

119 

Medtronic 

115 

Cordis, A 

Cardinal Health 

Company 

109 

PICS~AICS 

107 

Opsens 

105 

Getinge 

Group 

101 

Learn about cutting-edge products 

and pharmaceuticals in interventional 

and invasive cardiology. 

220 

Terumo 

Interventional 

Systems 

218 

Abiomed 

214 

Corindus 

Vascular 

Robotics 

208 

Gore & 

Associates 

206 

Medicure 

Pharma 

204 

Abbott 

202 

Bard 

Peripheral 

Vascular, Inc. 

221 

ACIST 

Medical 

Systems 

219 

Philips 

Volcano 

217 

St. Jude 

Medical 

215 

Edwards 

Lifesciences 

207 

Boston 

Scientific 

201 

Spectranetics 

316 

ZOLL 

314 

TandemLife 

308 

Chiesi USA, 

Inc. 

306 

Cook Medical 

300 

Sunday*: 9:45 AM – 6:15 PM 

Monday: 10:00 AM – 4:00 PM 

Tuesday**: 9:45 AM – 3:30 PM 

*Welcome Reception: Sunday, 5:15 PM – 6:15 PM 

**iPad Giveaway: Tuesday, 3:00 PM 

(Details on page 6) 

Abbott 

Booth 202 

www.abbott.com 

Abbott is a global healthcare 

company devoted to improving life 

through the development of 

products and technologies that 

D 

span the breadth of healthcare. 

With a portfolio of leading, 

science-based offerings in 

diagnostics, medical devices, 

nutritionals, and branded generic 

pharmaceuticals, Abbott serves 

people in more than 150 countries. 

Abiomed 

Booth 214 

www.abiomed.com 

Abiomed (NASDAQ: ABMD) is a 

pioneer and global leader in 

healthcare technology and 

innovation, with a mission of 

RECOVERING HEARTS AND 

SAVING LIVES. BLDG. Abiomed LEGEND: CEO, 

Michael R. Minogue, has focused 

the company’s efforts on 

developing ground-breaking 

technologies designed to assist or 

replace the life-sustaining pumping 

function of the failing heart. 

File Path: O:\NRDC\_FloorPlans\Shows\2016\12-Dec\SOC FOR CARDIOVASCULAR ANGIOGRAPHY & INTERVENTIONS (438564)\SCAI 16.dwg | Tab Name: 8.5x11P 

ACIST Medical Systems 

Booth 219 

www.acist.com 

ACIST, a Bracco Group company, 

offers innovative technologies that 

simplify cardiovascular procedures 

and empower clinicians. The 

portfolio includes: CVi variable rate 

contrast injector, RXi the first and 

only “Rapid FFR” MicroCatheter 

system and HDi High Definition 

IVUS system. DRAWING INFO 

Passport Line Item Number: 

# 

B. Braun Interventional 

Systems Facility: 

COSMOPOLITAN 

Booth 119 

www.bisusa.org Hall / Level: 

GRACIA BALLROOM 1,2,5 & 6 

B. Braun Interventional Systems, 

City & State: 

Inc. offers LAS state VEGAS, of the NV art medical 

technology Scale: designed CUSTOMwith the 

patient in 

Job 

mind, 

#: 438564 

and is a worldwide 

leader in Interventional Accessories. 

AE: MEREDITH MARTIN 

Many of these products were 

Prod. AE: MEREDITH MARTIN 

developed in response to the 

Started: 9/26/2016 

specific needs of physicians, 

Started By: BRIANNE MCDEDE 

technicians, and nurses in the field. 

Prod. Branch: LAS VEGAS 

Bard Peripheral Vascular, 

Inc. 

Booth 221 

www.bardpv.com 

ensure the accuracy of all information 

Bard Peripheral Vascular, Inc. 

provides a range of interventional 

medical devices including the 

Crosser ® CTO Recanalization 

Catheter designed to facilitate 

central lumen CTO recanalization, 

LifeStent ® verify all 

Solo TM dimension and locations. 

Vascular Stent 

System, and market leading offerings 

Disclaimer - Every effort has been made to 

contained on this floor plan. However, no 

warranties, either expressed of implied, are 

made with respect to this floor plan. If the 

location of building columns, utilities or other 

architectural components of the facility is a 

consideration in the construction or usage of 

an exhibit, it is the sole responsibility of the 

exhibitor to physically inspect the facility to 

© Copyright 2007, Freeman Co. All rights reserved. 

Confidential and Proprietary - the information 

contained herein is the proprietary information of 

Freeman and by accessing the information, the 

recipient agrees to keep the information 

confidential and not disclose it to any third party 

of Peripheral PTA Dilatation Catheters. 

Boston Scientific 

Booth 201 

www.bostonscientific.com 

without the prior consent of Freeman. Recipient 

also agrees to only use the information for its 

internal evaluation purposes and for no other 

purpose, without the prior consent of Freeman. 

20 

FINAL PROGRAM


(Continued) 

Boston Scientific transforms lives 

through innovative medical 

solutions that improve the health 

of patients around the world. As a 

global medical technology leader 

for more than 35 years, we advance 

science for life by providing a broad 

range of high-performance solutions 

that address unmet patient needs. 

Cardiovascular Systems, 

Inc. 

Booth 121 

www.csi360.com 

Cardiovascular Systems, Inc. (CSI), 

is devoted to developing and 

commercializing innovative 

solutions for treating peripheral 

and coronary vascular disease. Our 

primary focus is helping physicians 

conquer even the most difficult 

disease states, including calcium, 

given the complications it presents 

for the millions who suffer from 

PAD and CAD. 

Chiesi USA, Inc. 

Booth 306 

www.chiesiusa.com 

Chiesi USA is committed to 

developing and commercializing 

products that meet the needs of 

healthcare providers and their 

patients. We deliver our products 

and associated services to improve 

the lives of patients. 

Cook Medical 

Booth 300 

www.cookmedical.com 

Since 1963, Cook Medical has 

worked closely with physicians to 

develop technologies that eliminate 

the need for open surgery. We have 

always remained family-owned so 

that we have the freedom to focus 

on what we care about: patients, our 

employees, and our communities. 

Cordis a Cardinal Health 

Company 

Booth 109 

www.cordis.com 

Cordis, A Cardinal Health Company, 

is a worldwide leader in the 

development and manufacture of 

interventional cardiovascular and 

vascular technologies. Our products 

include self-expanding stents, 

catheters, balloons, guidewires, 

vena cava filters, as well as 

accessories and other devices. 

Cordis specializes in interventional 

procedures to deliver the best 

products, services, and outcomes. 

Corindus Vascular 

Robotics 

Booth 208 

www.corindus.com 

Corindus Vascular Robotics is a 

global technology leader in roboticassisted 

vascular interventions. The 

company’s CorPath ® System is the 

first FDA-cleared medical device to 

bring robotic-assisted precision to 

coronary and peripheral 

procedures. During the procedure, 

the interventional cardiologist sits 

at a radiation-shielded workstation 

to advance stents and guidewires 

with millimeter-by-millimeter 

precision. 

Edwards Lifesciences 

Booth 207 

www.edwards.com 

Edwards Lifesciences is the global 

leader in the science of heart valves 

and hemodynamic monitoring. 

Driven by a passion to help 

patients, the company partners 

with clinicians worldwide to 

develop innovative technologies in 

structural heart disease. 

Getinge Group 

Booth 101 

www.getingegroup.com 

Getinge Group is a leading global 

provider of products and systems 

that contribute to quality 

enhancement and cost efficiency 

within healthcare and life sciences. 

We operate under the three brands 

of ArjoHuntleigh, Getinge and 

Maquet. We build quality and safety 

into every system, and enhance 

efficiency throughout the clinical 

pathway. 

Gore & Associates 

Booth 206 

www.goremedical.com 

At Gore, we have provided creative 

therapeutic solutions to complex 

medical problems for more than 40 

years. During that time, more than 

40 million innovative Gore Medical 

Devices have been implanted, 

saving and improving the quality of 

lives worldwide. 

Medicure Pharma 

Booth 204 

www.medicure.com 

Medicure is a specialty 

pharmaceutical company focused 

on the development and 

commercialization of therapeutics 

for the U.S. hospital market. The 

Company’s current focus is in the 

area of acute cardiovascular care, 

a market served by its commercial 

product, AGGRASTAT (tirofiban HCl). 

Medtronic 

Booth 115 

www.medtronic.com 

As a global leader in medical 

technology, services, and solutions, 

Medtronic improves the lives and 

health of millions of people each 

year. We use our deep clinical, 

therapeutic, and economic 

expertise to address the complex 

challenges faced by healthcare 

systems today. Let’s take healthcare 

Further, Together. Learn more at 

Medtronic.com. 

Opsens 

Booth 105 

opsensmedical.com 

Opsens is focused on becoming a 

key player in the FFR world with 

the new OptoWire Deux. This is the 

first fiber-optic FFR guidewire with 

a nitinol core for breakthrough 

handling and functionality, an 

advanced fiber-optic sensor for 

superior accuracy. Our goal is the 

same as yours: better outcomes. 

Philips Volcano 

Booth 217 

www.volcanocorp.com 

Philips Volcano is a global leader in 

physiology and intravascular imaging 

for coronary and peripheral 

applications. The business also 

offers a suite of peripheral 

therapeutic devices. This is part of 

Philips’ industry-leading solutions 

to decide, guide, and confirm the 

right therapy for each patient in 

real-time. 

PICS~AICS 

Booth 107 

www.picsymposium.com 

PICS~AICS 2017 will be in Miami, 

January 16-19. The symposium will 

focus on the latest interventional 

catheter strategies for congenital 

and structural heart disease in 

children and adults. For program 

and registration information, go to 

www.picsymposium.com or 

contact 

kimberly_ray@pics-aics.com. 

SCAI 

Booth 220 

www.scai.org 

The Society for Cardiovascular 

Angiography and Interventions 

Foundation (SCAI) is the primary 

professional association for 

invasive and interventional 

cardiologists, Fellows-in-Training, 

and cardiovascular cath lab 

professionals, promoting 

excellence in invasive and 

interventional cardiovascular 

medicine through education, 

representation, and advancement 

of quality standards to enhance 

patient care. 

Spectranetics 

Booth 316 

www.spectranetics.com 

Spectranetics is dedicated to 

helping physicians cross, prep, and 

treat complex clinical challenges 

of Coronary and Peripheral Artery 

Disease, such as Chronic Total Occlusions, 

In-Stent Restenosis, vessel 

preparation, and Critical Limb 

Ischemia. We provide expert tools, 

training, and ongoing support so 

that you can help eradicate 

restenosis and amputation. Learn 

more, visit: www.spectranetics.com. 

St. Jude Medical 

Booth 215 

www.sjm.com 

St. Jude Medical is a leading global 

medical device manufacturer and 

is dedicated to transforming the 

treatment of some of the world’s 

most expensive epidemic diseases. 

The company has five major areas 

of focus, that include heart failure, 

atrial fibrillation, neuromodulation, 

traditional cardiac rhythm 

management, and cardiovascular 

diseases. 

TandemLife 

Booth 308 

www.tandemlife.com 

CardiacAssist, doing business as 

TandemLife ® , is the manufacturer 

of the most versatile Extracorporeal 

Life Support Platform. The 

TandemHeart ® pump & controller 

can be combined with our unique 

kits to support a variety of 

procedures. TandemLife has 

launched several new products 

since PROTEK Duo ® ; stop by our 

booth to learn more. 

Terumo Interventional 

Systems 

Booth 218 

www.terumois.com 

Terumo Interventional Systems (TIS) 

offers a complete, solution-based 

product portfolio used in advanced 

coronary and peripheral 

endovascular treatments with 

strategic initiatives in Transradial 

Access, Complex Coronary 

Intervention, and Critical Limb 

Ischemia. TIS combines 

innovative research and 

development to create a pipeline of 

industry-leading devices that deliver 

clinical value, economic benefit, 

and enhanced patient outcomes. 

ZOLL 

Booth 314 

www.ZOLL.com 

ZOLL Medical Corporation develops 

and markets products for 

defibrillation and monitoring, 

circulation and CPR feedback, data 

management, fluid resuscitation, 

therapeutic temperature management, 

and ventilation. ZOLL 

provides a comprehensive set of 

technologies that help clinicians, 

EMS and fire professionals, and 

lay rescuers treat victims needing 

resuscitation and acute critical care. 

EXHIBITOR INFORMATION 



21



SATELLITE SYMPOSIA 

Saturday, December 10 

H Use of Percutaneous 

Support Devices in 

Protected PCI and 

Cardiogenic Shock for Fellows 

Sunday, December 11 


Sponsored by Abiomed 

Presentations will address treatment 

of left main disease, chronic total 

occlusions, long lesions, bifurcation 

lesions, “small vessels,” saphenous 

vein grafts and treatment support 

strategies for patients presenting 

with cardiogenic shock. Participants 

B Master the Complex: L Congratulations. You L Closing the Gaps in D 

Techniques to Achieve Are an Interventional Care Across the 

Complete Revascularization Cardiologist. Now What? Lifetime of CHD Patients* 

6:30 AM – 8:00 AM | Castellana 1-2 12:15 PM – 1:15 PM | Castellana 1-2 12:15 PM – 1:15 PM | Brera 5-6 

Sponsored by Boston Scientific Sponsored by Medtronic 

Sponsored by Medtronic 

Educational Objectives: 

This symposium will focus on *For Congenital / Structural Heart 

• Increase awareness of BSC’s new all the facets of interventional Disease Course attendees only 

and forthcoming complex PCI cardiology for the new attending 

therapies, including Wolverine physician, including challenges and This symposium will highlight 

(cutting balloon), Sentai 

opportunities for young 

opportunities in adult congenital 

(guidewires), and RotaPro interventional cardiologists. 

cardiology for the new attending 

(rotational atherectomy). 

The speakers represent various physician, including challenges and 

• Understand rationale for and specialties, and the discussion opportunities for young interventional 

clinical application strategies of will be a reflection on what they cardiologists in CHD to include both 

cutting balloon plaque 

learned after their fellowships, and pediatric and adult CHD patients. 

modification in the context of how that can be applied today. Discussion will be a reflection on 

complex PCI case. 

The topics discussed will consist what they learned and how it can 

of technology, training, industry be applied in the future to help 

• Define appropriate application of 

partnerships, academic pursuits, address the mounting challenge of 

rotational atherectomy and learn 

and the changing landscape of managing CHD patients as more 

techniques to optimize cases with 

healthcare. Brief presentations will and more reach adulthood. Topics 

challenging calcium burden. 

be accompanied by a question and of discussion will include therapy 

• Learn about the design and answer period with an emphasis on awareness for adult congenital 

current experience with the Sentai 

guidewires and how they best 

available today to treat CHD 

audience participation. 

heart disease and the technology 

fit into the complex PCI toolbox. 

patients with RVOT anomalies. 

will learn how to manage challenging 

patient subsets, including advanced 

heart failure and depressed LVEF, 

as well as how to provide optimal 

hemodynamic support. 

Your Coronary and 

Peripheral Practice 

in the Next 10 Years: The 

Evolving Role of Imaging 

and Physiology in a 

Changing Healthcare 

Environment 


Sponsored by Philips Volcano 


• Understand the role of IVUS and 

physiology in establishing your 

practice today, both in coronary 

and peripheral procedures. 

• Recognize how advanced imaging 

with SyncVision (angiographic 

enhancement, IVUS and iFR 

co-registration) can add 

confidence to complex PCI. 

• Learn about the opportunity to 

address unmet needs in diagnosis 

and treatment of venous 

disease. 

MASTER THE 

COMPLEX 

Optimizing revascularization through 

innovation, training, and education. 

bostonscientific.com/MastertheComplex 

22 

FINAL PROGRAM 

All trademarks are the property of their respective owners. 

© 2016 Boston Scientific Corporation or its affiliates. All rights reserved. IC-431402-AA OCT2016 

VISIT BOOTH #201 

TO LEARN MORE

SATELLITE SYMPOSIA 

Monday, December 12 

B Translating Clinical Research into Clinical Care 


Sponsored by ZOLL 


• Know the benefits of randomized prospective trials. 

• Know the limitations of randomized prospective trials. 

• Recognize limitations of surrogate and composite endpoints. 

L PCI Optimization With OCT in Today’s Cath Lab 

Environment: A Case-Based Review Session 

12:15 PM – 1:15 PM | Castellana 1-2 (Concurrent Lunch Event 1) 

Sponsored by St. Jude Medical 

PCI Optimization with the usage of OCT is a rapidly growing segment 

of today’s cath lab interventions. Coronary imaging has become an 

intergyral part of current PCI practice with the advancement of recent 

stent platforms. This case-based review session, presented by leading 

physician experts on OCT, will demonstrate the clinical utility of OCT in a 

variety of lesion subsets, highlighting the ability to optimize outcomes. 

L 

Robotics in the Cath Lab: A Question of WHEN, Not IF 

12:15 PM – 1:15 PM | Brera 5-6 (Concurrent Lunch Event 2) 

Sponsored by Corindus 

Familiarizes participants with robotic-assisted PCI. The focus of the 

session is threefold: 1) provide an overview of robotic-assisted PCI 

including a step-by-step case demonstration; 2) illustrate the current 

benefits and future applications of cath lab robotics, and 3) provide a 

Fellow’s perspective on working with robotics. 

D IC Fellowship: What You Need to Know 


Sponsored by Cook Medical 

Offers a platform for Fellows to see cases, ask questions, and have a 

unique hands-on-learning experience. Fellows will walk away with a 

better understanding of peripheral arterial and venous procedures and 

what devices Cook offers to help them. 

Tuesday, December 13 

B 

Strategies to Simplify Complex Coronary and 

Peripheral Cases 


Sponsored by Spectranetics 

Introduces laser and Angiosculpt Technology to Interventional Fellows. 

Provides them with practical applications and a technology overview. 

L Antiplatelet Therapy for Contemporary PCI 


Sponsored by Chiesi USA, Inc. 

Promote understanding of the role of platelet inhibition for 

contemporary PCI and reviews the clinical guideline recommendations 

for antiplatelet therapy. 

L 

Transcatheter Pulmonic Valve Replacement (TPVR)* 

12:15 PM – 1:15 PM | Brera 2-3 

Sponsored by Edwards Lifesciences 

*For Congenital / Structural Heart Disease Course attendees only 

Learn more about a recently approved therapy for pulmonic valve 

replacement. The Edwards SAPIEN XT balloon-expandable transcatheter 

heart valve provides an important, minimally invasive option for the 

treatment of pediatric and adult patients with pulmonary valve disease. 

D 

Successful TAVR Procedural Planning through 

Advanced Imaging 


Sponsored by Edwards Lifesciences 

The role of imaging has evolved as TAVR has advanced; imaging 

modalities like echocardiography and cardiac CT have become 

indispensable tools for safe procedure planning. Participants will hear 

from experts in both echo and cardiac CT, review challenging cases, 

understand the unique differences between the two modalities, and 

have an opportunity to participate in a case work-up. 

Melody Transcatheter Pulmonary Valve 

Ensemble II Transcatheter Valve Delivery System 

Important Labeling Information for United States 

Indications: The Melody TPV is indicated for use as an adjunct to surgery in the 

management 

of pediatric and adult patients with the following clinical conditions: 

· Existence of a full (circumferential) RVOT conduit that was equal to or greater than 16 

mm in diameter when originally implanted AND 

· Dysfunctional RVOT conduits with a clinical indication for intervention, AND 

- regurgitation: ≥ moderate regurgitation, AND/OR 

- stenosis: mean RVOT gradient ≥ 35 mm Hg 

Contraindications: None known. 

Warnings/Precautions/Side Effects: 

· DO NOT implant in the aortic or mitral position. Preclinical bench testing of the Melody 

valve suggests that valve function and durability will be extremely limited when used in 

these locations. 

· DO NOT use if patient’s anatomy precludes introduction of the valve, if the venous 

anatomy cannot accommodate a 22 Fr size introducer, or if there is significant 

obstruction of the central veins. 

· DO NOT use if there are clinical or biological signs of infection including active 

endocarditis. Standard medical and surgical care should be strongly considered in these 

circumstances. 

· Assessment of the coronary artery anatomy for the risk of coronary artery compression 

should be performed in all patients prior to deployment of the TPV. 

· To minimize the risk of conduit rupture, do not use a balloon with a diameter greater than 

110% of the nominal diameter (original implant size) of the conduit for pre-dilation of the 

intended site of deployment, or for deployment of the TPV. 

· The potential for stent fracture should be considered in all patients who undergo TPV 

placement. Radiographic assessment of the stent with chest radiography or fluoroscopy 

should be included in the routine postoperative evaluation of patients who receive a TPV. 

· If a stent fracture is detected, continued monitoring of the stent should be performed in 

conjunction with clinically appropriate hemodynamic assessment. In patients with stent 

fracture and significant associated RVOT obstruction or regurgitation, reintervention 

should be considered in accordance with usual clinical practice. 

Potential procedural complications that may result from implantation of the Melody 

device include the following: rupture of the RVOT conduit, compression of a coronary 

artery, perforation of a major blood vessel, embolization or migration of the device, 

perforation of a heart chamber, arrhythmias, allergic reaction to contrast media, 

cerebrovascular events (TIA, CVA), infection/sepsis, fever, hematoma, radiationinduced 

erythema, blistering, or peeling of skin, pain, swelling, or bruising at the 


Potential device-related adverse events that may occur following device implantation 

include the following: stent fracture, *stent fracture resulting in recurrent obstruction, 

endocarditis, embolization or migration of the device, valvular dysfunction (stenosis or 

regurgitation), paravalvular leak, valvular thrombosis, pulmonary thromboembolism, 

hemolysis. 

* The term “stent fracture” refers to the fracturing of the Melody TPV. However, in 

subjects with multiple stents in the RVOT it is difficult to definitively attribute stent 

fractures to the Melody frame versus another stent. 

For additional information, please refer to the Instructions For Use provided with the 

product. 

CAUTION: Federal law (USA) restricts this device to sale by or on the order of a physician. 

Important Labeling Information for 

Geographies Outside of the United States 

Indications: The Melody Transcatheter Pulmonary Valve is indicated for use in patients 

with the following clinical conditions: 

· Patients with regurgitant prosthetic Right Ventricular Outflow Tract (RVOT) conduits 

with a clinical indication for invasive or surgical intervention, OR 

· Patients with stenotic prosthetic RVOT conduits where the risk of worsening 

regurgitation is a relative contraindication to balloon dilation or stenting. 

· Existence of a full (circumferential) RVOT conduit that was equal to or greater than 16 

mm in diameter when originally implanted. 

The intended lifetime for the Melody device is 2 years. 

Contraindications: 

· Venous anatomy unable to accommodate a 22 Fr size introducer sheath; implantation in 

left heart. 

· Unfavorable right ventricular outflow tract for good stent anchorage. 

· Severe right ventricular outflow obstruction, which cannot be dilated by balloon. 

· Obstruction of the central veins. 

· Clinical or biological signs of infection. 

· Active endocarditis. 

· Known allergy to aspiring or heparin. 

· Pregnancy. 

Potential Complications/Adverse Events: Potential procedural complications that 

may result from implantation of the Melody device include the following: rupture of the 

RVOT conduit, compression of a coronary artery, perforation of a major blood vessel, 

embolization or migration of the device, perforation of a heart chamber, arrhythmias, 

allergic reaction to contrast media, cerebrovascular events (TIA, CVA), infection/sepsis, 

fever, hematoma, radiation-induced erythema, pain at the catheterization site. 

Potential device-related adverse events that may occur following device implantation 

include the following: stent fracture resulting in recurrent obstruction, endocarditis, 

embolization or migration of the device, valvular dysfunction (stenosis or regurgitation), 

paravalvular leak, valvular thrombosis, pulmonary thromboembolism, hemolysis. 

For additional information, please refer to the Instructions For Use provided with the 

product. 

The Melody Transcatheter Pulmonary Valve and Ensemble II Transcatheter Delivery 

System has received CE Mark approval and is available for distribution in Europe.

10 YEARS. 

10,000 PATIENTS . 

1 LIFE-CHANGING 

VALVE. 

Melody 

Transcatheter Pulmonary 

Valve Therapy 

Designed Specifically 

For Pulmonary 

Valve Replacement 

The Melody valve is the longest 

studied transcatheter valve and is 

proven to delay conduit replacement: 

88.8% 

freedom from 

reoperation at 7 years 

post-implant * 

* 

US IDE Study 

Melody-TPV.com 

The Melody TPV System first received CE mark in September, 2006. 

The Melody TPV System received Health Canada approval in December 2006 

and US approval under an HDE on January 25, 2010 (H080002). 

PMA approval received January 27, 2015 (P140017). 

Medtronic, Medtronic logo and Further, Together are trademarks of Medtronic. 

All other brands are trademarks of a Medtronic company. 

710 Medtronic Parkway 

Minneapolis, MN 55432-5604 

USA 

Tel: (763) 514-4000 

Fax: (763) 514-4879 

Toll-free: (800) 328-2518 

LifeLine 

CardioVascular Technical Support 

Tel: (877) 526-7890 

Tel: (763) 526-7890 

Fax: (763) 526-7888 

rs.cstechsupport@medtronic.com 

UC201607890 EN 10/2016 ©2016 Medtronic. All rights reserved.

FALL FELLOWS

Create successful ePaper yourself

Delete template?

Save as template?